Asia-Pacific Point-of-care Diagnostic Market – Size, Outlook, Trends and Forecast (2024

Asia-Pacific Point-of-care Diagnostic Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Point-of-care testing is medical diagnostic testing or near point-of-care testing. Point-of-care tests are simple medical tests that are performed and develop new technology to mask the complexity. Connectivity is an important part of the point-of-care market.

Asia-Pacific Point-of-care Diagnostic Market Segments size & growth:

The market is valued at $ 2.603 billion in 2017 and is projected to $ 4.344 billion by 2024 at a CAGR of 9.9%. The significant factors that are driving the growth of the market are an increase in awareness and inclination towards home health care, and prevalence of lifestyle and infectious disease and demand for the market is expected to grow in the further years. Rapid growth in ageing population, advancements in technology and increase in some chronic diseases.

Asia-Pacific Point-of-care Diagnostic Market Share:

Point-of-care diagnostics market is categorised by by-product, mode of delivery and end user. By

Asia-Pacific Point-of-care Diagnostic Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

by-product, it is segmented into infectious disease, glucose monitoring kit, oncology markers, coagulation, drugs of abuse and blood gas testing and others. Based on the mode of delivery the market is categorised into OTC testing and prescription. And based on end users the market is segmented into research laboratories, home health care, and hospitals. As by-product categorises the market, mode of delivery and end user the market equally constitutes the market share in all the categories like hospitals, research laboratories and home health care, testing and monitoring. Geographically, Asia-Pacific is a fastest growing segment and exhibit strong growth rate during the forecast (2018-24)

Asia-Pacific Point-of-care Diagnostic Market Trends:

Roche, Alere, Abbott, and Siemens are the ones which are the most significant companies regarding point-of-care diagnostics market revenues and these companies together make three-fourths of entire POC diagnostics market.
Waltham, MA-based Alere secured the second market position and participated in nearly all the POC segments but dominates in cardiac markers.

Asia-Pacific Point-of-care Diagnostic Market Research Reports Include:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players are:

Abbott Laboratories
Siemens AG
Johnson & Johnson
Alere Inc.
Nova Biomedical
Roche Diagnostics

market. Waltham, MA-based Alere

You can also purchase parts of this report. Do you want to check out a section wise price list

Asia-Pacific Point-of-care Diagnostic Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.